Health & Environmental Research Online (HERO)


Print Feedback Export to File
7568045 
Journal Article 
The influence of bambuterol (carbamylated terbutaline) on the duration of action of succinylcholine-induced paralysis in humans 
Fisher, DM; Caldwell, JE; Sharma, M; Wirén, JE; , 
1988 
1 
Anesthesiology
ISSN: 0003-3022
EISSN: 1528-1175 
LIPPINCOTT-RAVEN PUBL 
PHILADELPHIA 
69 
5 
757-759 
English 
3056118 
WOS:A1988Q772100020 
Bambuterol (bis-dimethylcarbamyalated terbutaline) is being investigated as an orally administered prolonged-acting treatment for bronchospasm. Adding two carbamate groups to terbutaline results in bambuterol, an inert prodrug compound that is broken enzymatically to yield the active compound, terbutaline. Because bambuterol is slowly bioconverted, has a high affinity for lung tissue, and is bioconverted in the lung, it can be administered once daily for the treatment of asthma. However, as the carbamate groups are cleaved from bambuterol, they selectively inhibit the activity of pseudocholinesterase, the enzyme responsible for the degradation of succinylcholine. Therefore, we determined the interaction of bambuterol-induced decreases in pseudocholinesterase activity and succinylcholine-induced neuromuscular blockade. 
bambuterol; suxamethonium; adult; anesthesia; controlled study; human; human experiment; intravenous drug administration; neuromuscular blocking; paralysis; priority journal 
Other
• Harmful Algal Blooms- Health Effects
     April 2021 Literature Search
          Scopus